(19)
(11) EP 1 171 595 A1

(12)

(43) Date of publication:
16.01.2002 Bulletin 2002/03

(21) Application number: 00922200.1

(22) Date of filing: 12.04.2000
(51) International Patent Classification (IPC)7: C12N 15/12, C07K 14/705, C07K 16/28, C12Q 1/68, G01N 33/68, A61P 13/08, A61K 38/17, A61K 39/395, A01K 67/027
(86) International application number:
PCT/US0010/039
(87) International publication number:
WO 0061/746 (19.10.2000 Gazette 2000/42)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 12.04.1999 US 128858 P

(71) Applicant: Agensys, Inc.
Santa Monica, CA 90404 (US)

(72) Inventors:
  • AFAR, Daniel, E.
    Pacific Palisades, CA 90272 (US)
  • HUBERT, Rene, S.
    Los Angeles, CA 90026 (US)
  • LEONG, Kahan
    Playa del Rey, CA 90293 (US)
  • RAITANO, Arthur, B.
    Los Angeles, CA 90064 (US)
  • SAFFRAN, Douglas, C.
    Los Angeles, CA 90049 (US)

(74) Representative: W.P. Thompson & Co. 
Coopers Building, Church Street
Liverpool L1 3AB
Liverpool L1 3AB (GB)

   


(54) 13 TRANSMEMBRANE PROTEIN EXPRESSED IN PROSTATE CANCER